ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00230672
Recruitment Status : Unknown
Verified August 2008 by Imperial College London.
Recruitment status was:  Recruiting
First Posted : October 3, 2005
Last Update Posted : August 13, 2008
Sponsor:
Information provided by:
Imperial College London

September 29, 2005
October 3, 2005
August 13, 2008
March 2005
Not Provided
Not Provided
Not Provided
Complete list of historical versions of study NCT00230672 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Investigation of Plasma Proteins in Patients With Hereditary Haemorrhagic Telangiectasia and PAVMs
Studies of Plasma Proteins Derived From Pulmonary Arteriovenous Malformation Patients
Hereditary Haemorrhagic Telangiectasia (HHT, also known as Osler-Weber-Rendu Syndrome) is an disease that leads to the development of dilated and fragile blood vessels, including arteriovenous malformations in the lungs (PAVMs). We hypothesize that the genetically-determined abnormality in the blood vessels of HHT patients leads to alteration in the concentrations or activity of several proteins in the blood stream. We propose to take blood samples from patients at defined times in order to study changes in blood protein levels and activity
Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Not Provided
Not Provided
Telangiectasia, Hereditary Hemorrhagic
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
70
Same as current
Not Provided
Not Provided

Inclusion Criteria:Patients with hereditary haemorrhagic telangiectasia and pulmonary arteriovenous malformations -

Exclusion Criteria:Unable to provide informed consent

Sexes Eligible for Study: All
Child, Adult, Older Adult
No
Contact information is only displayed when the study is recruiting subjects
United Kingdom
 
 
NCT00230672
IC/CLS7
Not Provided
Not Provided
Not Provided
Not Provided
Imperial College London
Not Provided
Principal Investigator: Claire Shovlin Imperial College London
Imperial College London
August 2008